Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene

Abstract

The small packaging capacity of adeno-associated virus (AAV) vectors limits the utility of this promising vector system for transfer of large genes. We explored the possibility that larger genes could be reconstituted following homologous recombination between AAV vectors carrying overlapping gene fragments. An alkaline phosphatase (AP) gene was split between two such AAV vectors (rec vectors) and packaged using AAV2 or AAV6 capsid proteins. Rec vectors having either capsid protein recombined to express AP in cultured cells at about 1–2% of the rate observed for an intact vector. Surprisingly, the AAV6 rec vectors transduced lung cells in mice almost as efficiently as did an intact vector, with 10% of airway epithelial cells, the target for treatment of cystic fibrosis (CF), being positive. Thus AAV rec vectors may be useful for diseases such as CF that require transfer of large genes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: AAV vector constructs.
Figure 2: Transduction efficiency of rec vectors.
Figure 3: PCR analysis of DNA from CF16 cells transduced with AAV rec vectors.
Figure 4: Analysis of AAV vector transduction in mouse lung.
Figure 5: Quantitation of transduction rates in mouse lungs five to seven weeks after vector exposure.

Similar content being viewed by others

References

  1. Muzyczka, N. Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr. Top. Microbiol. Immunol. 158, 97–129 (1992).

    CAS  PubMed  Google Scholar 

  2. Halbert, C.L., Rutledge, E.A., Allen, J.M., Russell, D.W. & Miller, A.D. Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes. J. Virol. 74, 1524–1532 (2000).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Fisher, K.J. et al. Recombinant adeno-associated virus for muscle-directed gene therapy. Nat. Med. 3, 306–312 (1997).

    Article  CAS  PubMed  Google Scholar 

  4. Herzog, R.W. et al. Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat. Med. 5, 56–63 (1999).

    Article  CAS  PubMed  Google Scholar 

  5. Kessler, P.D. et al. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. USA 93, 14082–14087 (1996).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Snyder, R.O. et al. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat. Genet. 16, 270–276 (1997).

    Article  CAS  PubMed  Google Scholar 

  7. Xiao, X., Li, J. & Samulski, R.J. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70, 8098–8108 (1996).

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Xiao, W. et al. Gene therapy vectors based on adeno-associated virus type 1. J. Virol. 73, 3994–4003 (1999).

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Chao, H. et al. Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. Mol. Ther. 2, 619–623 (2000).

    Article  CAS  PubMed  Google Scholar 

  10. Hildinger, M. et al. Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer. J. Virol. 75, 6199–6203 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Davidson, B.L. et al. Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc. Natl. Acad. Sci. USA 97, 3428–3432 (2000).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Zabner, J. et al. Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer. J. Virol. 74, 3852–3858 (2000).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Halbert, C.L., Allen, J.M. & Miller, A.D. Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors. J. Virol. 75, 6615–6624 (2001).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Zhang, L. et al. Efficient expression of CFTR function with adeno-associated virus vectors that carry shortened CFTR genes. Proc. Natl. Acad. Sci. USA 95, 10158–10163 (1998).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Flotte, T.R. et al. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc. Natl. Acad. Sci. USA 90, 10613–10617 (1993).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Sun, L., Li, J. & Xiao, X. Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization. Nat. Med. 6, 599–602 (2000).

    Article  CAS  PubMed  Google Scholar 

  17. Yan, Z., Zhang, Y., Dongsheng, D. & Engelhardt, J.F. Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy. Proc. Natl. Acad. Sci. USA 97, 6716–6721 (2000).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Nakai, H., Storm, T.A. & Kay, M.A. Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors. Nat. Biotechnol. 18, 527–532 (2000).

    Article  CAS  PubMed  Google Scholar 

  19. Duan, D., Yue, Y. & Engelhardt, J.F. Expanding AAV packaging capacity with trans-splicing or overlapping vectors: a quantitative comparison. Mol. Ther. 4, 383–391 (2001).

    Article  CAS  PubMed  Google Scholar 

  20. Johnson, L.G. et al. Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Nat. Genet. 2, 21–25 (1992).

    Article  CAS  PubMed  Google Scholar 

  21. Graham, F.L. & Smiley, J. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59–72 (1977).

    Article  CAS  PubMed  Google Scholar 

  22. Allen, J.M., Halbert, C.L. & Miller, A.D. Improved adeno-associated virus vector production with transfection of a single helper adenovirus gene, E4orf6. Mol. Ther. 1, 88–95 (2000).

    Article  CAS  PubMed  Google Scholar 

  23. Halbert, C.L. et al. Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration. J. Virol. 71, 5932–5941 (1997).

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Hirt, B. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26, 365–369 (1967).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank John M. Alfano and Stephanie R. Moe for excellent technical assistance. This work was supported by grants DK47754 and HL66947 from the National Institutes of Health.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Dusty Miller.

Ethics declarations

Competing interests

The authors own small amounts of stock in several gene therapy companies and may share in royalties from patents covering inventions related to vector development which are owned by the Fred Hutchinson Cancer Research Center.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Halbert, C., Allen, J. & Miller, A. Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene. Nat Biotechnol 20, 697–701 (2002). https://doi.org/10.1038/nbt0702-697

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0702-697

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing